542 related articles for article (PubMed ID: 33477086)
21. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
22. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
[TBL] [Abstract][Full Text] [Related]
23. In Situ Decarboxylation-Pressurized Hot Water Extraction for Selective Extraction of Cannabinoids from
Nuapia Y; Maraba K; Tutu H; Chimuka L; Cukrowska E
Molecules; 2021 Jun; 26(11):. PubMed ID: 34199346
[TBL] [Abstract][Full Text] [Related]
24. Cis-Δ
Tolomeo F; Russo F; Kaczorova D; Vandelli MA; Biagini G; Laganà A; Capriotti AL; Paris R; Fulvio F; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
J Pharm Biomed Anal; 2022 Sep; 219():114958. PubMed ID: 35930832
[TBL] [Abstract][Full Text] [Related]
25. THC-Reduced
Bartkowiak-Wieczorek J; Mądry E; Książkiewicz M; Winkler-Galicki J; Szalata M; Szalata M; Jiménez UE; Wielgus K; Grześkowiak E; Słomski R; Bienert A
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375550
[TBL] [Abstract][Full Text] [Related]
26. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.
Zeyl V; Sawyer K; Wightman RS
Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675
[No Abstract] [Full Text] [Related]
27. Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland.
Grafinger KE; Krönert S; Broillet A; Weinmann W
Forensic Sci Int; 2020 May; 310():110261. PubMed ID: 32229319
[TBL] [Abstract][Full Text] [Related]
28. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
29. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
30. Comment on Lachenmeier
Kruse D; Beitzke B
F1000Res; 2020; 9():900. PubMed ID: 32864108
[TBL] [Abstract][Full Text] [Related]
31. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.
De Backer B; Debrus B; Lebrun P; Theunis L; Dubois N; Decock L; Verstraete A; Hubert P; Charlier C
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4115-24. PubMed ID: 19932642
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
33. Cannabidiol in urine is not a proof of CBD consumption-lesson learned from urine sample analysis in routine caseworks.
Deville M; Charlier C
Forensic Toxicol; 2023 Jul; 41(2):213-220. PubMed ID: 36481827
[TBL] [Abstract][Full Text] [Related]
34. A validated method for the simultaneous quantification of cannabidiol, Δ
Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
[TBL] [Abstract][Full Text] [Related]
35. A Comparative Approach to Screen the Capability of Raman and Infrared (Mid- and Near-) Spectroscopy for Quantification of Low-Active Pharmaceutical Ingredient Content Solid Dosage Forms: The Case of Alprazolam.
Makraduli L; Makreski P; Goracinova K; Stefov S; Anevska M; Geskovski N
Appl Spectrosc; 2020 Jun; 74(6):661-673. PubMed ID: 32031007
[TBL] [Abstract][Full Text] [Related]
36. THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects?
Havig SM; Høiseth G; Strand MC; Karinen RA; Brochmann GW; Strand DH; Bachs L; Vindenes V
Forensic Sci Int; 2017 Jul; 276():12-17. PubMed ID: 28463706
[TBL] [Abstract][Full Text] [Related]
37. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
38. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA
Front Public Health; 2022; 10():893009. PubMed ID: 35784239
[TBL] [Abstract][Full Text] [Related]
39. Determination of Cannabinoids in Cannabis sativa Oil and Infused Ice Cream by LC-DAD Method.
Raslan-Jaramillo JJ; Ríos-Gajardo GA; Avello MA; de Diego MG
J AOAC Int; 2024 Jan; 107(1):140-145. PubMed ID: 37819769
[TBL] [Abstract][Full Text] [Related]
40. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
Shi Y; Cao Y; Shang C; Pacula RL
Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
